Hair Growth · Licensed programs · Science from Aneira Pharma
Growth built onfollicle biology.
Two clinical-development programs built on shared follicle-biology science, spanning pattern hair loss and eyebrow density.
Programs
Two programs. One area of science.
Select a program to view its development focus.
Program objective
Hair-growth program targeting the biological pathways involved in pattern hair loss.
Mechanism — high level
Designed to act on follicular signalling pathways involved in the hair growth cycle, with the aim of increasing hair density and improving hair thickness and quality.
Development status
In clinical development. Further updates will be communicated as the program progresses.
Road to market
Development status — all programs presented are currently in research and development. Potential indications and applications reflect development objectives and do not represent established efficacy, safety or regulatory approval.
Development rationale
The thinking behind the science.
01
Why hair growth
Hair-related concerns are among the most common reasons for consultations in dermatology and aesthetic medicine practices, while available pharmacological treatment options remain limited. Each program focuses on a different, clearly defined clinical problem in this area.
02
Why one area of science
The shared follicle biology of the scalp and eyebrows allows knowledge gained in individual programs — on tolerability and outcome assessment — to be applied across both hair-growth programs. This approach may reduce development risk compared with focusing on a single program.
03
Why now
Demand for physician-led hair-restoration therapies continues to grow worldwide, while the number of pharmaceutical solutions grounded in robust scientific evidence remains limited. This gap between patient need and available treatment options creates significant room for innovation.
Work with us
Let’s advancehair growth together.
Let's build the business together. Contact our Business Development team.